Commentary|Podcasts|August 31, 2023
Managed Care Cast Presents: Stakeholders Summit—Biosimilars in Inflammatory Diseases, Part 1
Author(s)Laura Joszt, MA
In part 1 of this 2-part podcast, a panel of experts discusses the clinical manifestations of inflammatory diseases and the potential for biosimilars to treat these diseases.
Advertisement
Today we are bringing you part 1 of a 2-part sponsored podcast series discussing the use of biosimilars in inflammatory diseases. The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.
The conversation for today’s podcast includes the clinical manifestation of inflammatory diseases, comorbid conditions, and the role of biologics and biosimilars in disease management.
Listen above or through one of these podcast services:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
Cardiology Prices Vary Widely by Insurer and State
3
Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia
4
Medicaid MFN Pricing Could Save $8.6 Billion
5